In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci.
about
Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odysseyIdentification and phenotypic characterization of a beta-lactam-dependent, methicillin-resistant Staphylococcus aureus strainGuidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA).Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
P2860
In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
In vitro activities of a novel ...... ate susceptible staphylococci.
@ast
In vitro activities of a novel ...... ate susceptible staphylococci.
@en
type
label
In vitro activities of a novel ...... ate susceptible staphylococci.
@ast
In vitro activities of a novel ...... ate susceptible staphylococci.
@en
prefLabel
In vitro activities of a novel ...... ate susceptible staphylococci.
@ast
In vitro activities of a novel ...... ate susceptible staphylococci.
@en
P2093
P2860
P1476
In vitro activities of a novel ...... ate susceptible staphylococci.
@en
P2093
Michael J Rybak
Vanthida Huang
William J Brown
P2860
P304
P356
10.1128/AAC.48.7.2719-2723.2004
P407
P577
2004-07-01T00:00:00Z